Regeneron

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Regeneron 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

Stock Snapshot

As of today, Regeneron(REGN) shares are valued at $741.29.

On 2025-12-14, Regeneron(REGN) stock opened at —, reached a high of —, and a low of —.

REGN News

Nasdaq 1d
Benjamin Graham Detailed Fundamental Analysis - REGN

Below is Validea's guru fundamental report for REGENERON PHARMACEUTICALS INC (REGN). Of the 22 guru strategies we follow, REGN rates highest using our Value Inv...

Benjamin Graham Detailed Fundamental Analysis - REGN
TipRanks 2d
Regeneron price target raised to $768 from $767 at Morgan Stanley

Morgan Stanley analyst Terence Flynn raised the firm’s price target on Regeneron (REGN) to $768 from $767 and keeps an Equal Weight rating on the shares. The fi...

TipRanks 4d
Regeneron price target raised to $985 from $890 at HSBC

HSBC raised the firm’s price target on Regeneron (REGN) to $985 from $890 and keeps a Buy rating on the shares as part of a 2026 outlook for the pharma group. T...

Analyst ratings

67%

of 30 ratings
Buy
66.7%
Hold
30%
Sell
3.3%

More REGN News

Simply Wall St 4d
Regeneron: Revisiting Valuation After a Short-Term Pullback and Longer-Term Shareholder Weakness

Advertisement Market context and recent performance Regeneron Pharmaceuticals (REGN) has been drifting lower in the past week, even after a solid run over the...

Regeneron: Revisiting Valuation After a Short-Term Pullback and Longer-Term Shareholder Weakness
Nasdaq 6d
Regeneron Reports Promising Phase 1/2 Data Of Lynozyfic In Newly Diagnosed Multiple Myeloma

(RTTNews) - Regeneron Pharmaceuticals Inc. (REGN) announced encouraging results from the Phase 1/2 LINKER-MM4 trial evaluating Lynozyfic (linvoseltamab) in adul...

Regeneron Reports Promising Phase 1/2 Data Of Lynozyfic In Newly Diagnosed Multiple Myeloma

People also own

Based on the portfolios of people who own REGN. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.